<a href="https://www.fiercebiotech.com/cro/flaws-are-being-scaled-not-solved-ai-clinical-trials-report" hreflang="en">Clinical trial flaws ‘being scaled, not solved’ by AI: report</a>
fiercebiotech.com·May 18, 2026
Phesi's analysis reveals that less than one-third of clinical trial protocols are linked to documented patient data and outcomes, raising concerns about potential flawed decision-making in clinical development.
For a professional in healthtech and biotech, the key takeaway is the critical need to integrate documented patient data and outcomes into clinical trial protocols to enhance decision-making accuracy. This insight underscores the investment opportunity in platforms or technologies that facilitate better data integration and management in clinical trials, potentially reducing the risk of flawed decisions and improving trial success rates.